v3.26.3
Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Reconciliation of cash and cash equivalents and restricted cash presented on the consolidated statements of cash flows    
Cash and cash equivalents $ 29,854 [1] $ 12,123
Restricted cash 10,974 [1] 9,136
Total cash and cash equivalents and restricted cash 40,828 21,259
Supplemental disclosure of non-cash investing and financing activity:    
Dividends declared to common shareholders 12,765 12,788
Loan extension fee receivable 2,400  
Non-cash interest accrued to debt balances 2,931 2,123
Accrued acquisition costs 329 $ 699
Accrued stock repurchases $ 1,468  
[1] Refer to Note 2 for details on the Company’s consolidated variable interest entities (“VIEs”).